Literature DB >> 12814775

Animal models of Helicobacter pylori infection and disease.

Jani L O'Rourke1, Adrian Lee.   

Abstract

The acceptance of Helicobacter pylori as a major human pathogen has necessitated the development of animal models to help elucidate the pathogenic mechanisms of this bacterium and aid in the development of improved strategies for the treatment of gastric disease. Appropriate models, utilising a range of animal species, have been developed to examine factors such as the influence of host responses and bacterial factors in disease development and the success of new therapeutic regimens, including vaccination, to cure infection.

Entities:  

Mesh:

Year:  2003        PMID: 12814775     DOI: 10.1016/s1286-4579(03)00123-0

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  22 in total

1.  The Helicobacter pylori cag pathogenicity island protein CagN is a bacterial membrane-associated protein that is processed at its C terminus.

Authors:  Kevin M Bourzac; Laura A Satkamp; Karen Guillemin
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  An ABC transporter and a TonB ortholog contribute to Helicobacter mustelae nickel and cobalt acquisition.

Authors:  Jeroen Stoof; Ernst J Kuipers; Gerard Klaver; Arnoud H M van Vliet
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection.

Authors:  Taslima T Lina; Irina V Pinchuk; Jennifer House; Yoshio Yamaoka; David Y Graham; Ellen J Beswick; Victor E Reyes
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

4.  Mouse Models Of Helicobacter Infection And Gastric Pathologies.

Authors:  Kimberley D'Costa; Michelle Chonwerawong; Le Son Tran; Richard L Ferrero
Journal:  J Vis Exp       Date:  2018-10-18       Impact factor: 1.355

Review 5.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  N-acetylcysteine prevents the development of gastritis induced by Helicobacter pylori infection.

Authors:  Sungil Jang; Eun-Jung Bak; Jeong-Heon Cha
Journal:  J Microbiol       Date:  2017-04-29       Impact factor: 3.422

Review 7.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  Disruption of sncRNA Improves the Protective Efficacy of Outer Membrane Vesicles against Helicobacter pylori Infection in a Mouse Model.

Authors:  Biaoxian Li; Yilian Xu; Tian Xu; Zhicheng Guo; Qianwen Xu; Yi Li; Lingbin Zeng; Xiaotian Huang; Qiong Liu
Journal:  Infect Immun       Date:  2022-07-21       Impact factor: 3.609

9.  Helicobacter suis causes severe gastric pathology in mouse and mongolian gerbil models of human gastric disease.

Authors:  Bram Flahou; Freddy Haesebrouck; Frank Pasmans; Katharina D'Herde; Ann Driessen; Kim Van Deun; Annemieke Smet; Luc Duchateau; Koen Chiers; Richard Ducatelle
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

10.  In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection.

Authors:  Sina Bartfeld; Tülay Bayram; Marc van de Wetering; Meritxell Huch; Harry Begthel; Pekka Kujala; Robert Vries; Peter J Peters; Hans Clevers
Journal:  Gastroenterology       Date:  2014-10-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.